Endpoints
By ALS TDI
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by ALS TDI
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 3
Reviews: 0
Episodes: 58
Description
The Endpoints Podcast features guests from the ALS community, including people living with ALS, researchers, advocates and fundraisers. Each episode cuts to the chase with short, digestible conversations about the latest research at ALS TDI and the most closely watched ALS clinical trials as well as stories from people living with ALS with their thoughts on research, healthcare and their journey with ALS.
The Endpoints Podcast is hosted by the ALS Therapy Development Institute (ALS TDI) the world's foremost drug discovery lab focused solely on ALS. ALS TDI is a non-profit biotech with one mission. End ALS.
To access all episodes of the Endpoints Podcast, visit als.net/endpoints.
| Episode | Date |
|---|---|
|
Many Shades of ALS: Supporting People of Color with ALS
|
Feb 12, 2024 |
|
Roon: A New App for Navigating ALS with Help from Experts
|
Oct 31, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on PTC Therapeutics PTC 857
|
Sep 29, 2023 |
|
Go On, Be Brave and Hope Fights Back: Andrea Lytle Peet on Her New Film and Book
|
Sep 15, 2023 |
|
Could Accelerometers Provide More Sensitive Measures of ALS than the ALSFRS-r?
|
Sep 01, 2023 |
|
ALS TDI and Unite Genomics Partner to Bring Electronic Health Record Data into the ARC Study
|
Aug 18, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on Novartis Pharmaceuticals' BLZ945
|
Aug 04, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on AL-S Pharma's AP-101
|
Jul 24, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on Annexon's ANX005
|
Jul 06, 2023 |
|
The ALS Research Collaborative: How Your Participation can Accelerate ALS Research
|
Jun 29, 2023 |
|
Racing for ALS Update: Scott Lloyd on the Past 3 Years of Racing Cars and Raising Funds for Research
|
Jun 09, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on MedicNova's Ibudilast Clinical Trial
|
May 26, 2023 |
|
Rinaldo and Sara Dorman: What Keeps Us Coming Back to the Tri-State Trek
|
May 15, 2023 |
|
Jean Swidler: Fighting for the Needs of ALS-Related Gene Carriers
|
Apr 13, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on AB Science’s Masitinib Clinical Trial
|
Mar 31, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on Cytokinetics’ Terminated Reldesemtiv Clinical Trial
|
Mar 23, 2023 |
|
Brooke Eby: Spreading ALS Awareness Through TikTok
|
Mar 16, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on Biogen's Tofersen Trial for Presymptomatic Carriers
|
Mar 10, 2023 |
|
Copper Complexes: Dr. Fernando Vieira on ALS TDI's Promising Potential ALS Treatment
|
Mar 03, 2023 |
|
Endpoints Shorts: Dr. Nadia Sethi on Ionis' FUS ASO Trial
|
Feb 28, 2023 |
|
Google’s Project Relate: Using Machine Learning to Help People with ALS
|
Feb 17, 2023 |
|
Dr. Silvia Pozzi on the State of Antibody Therapies for ALS
|
Sep 06, 2022 |
|
Ajay Sampat: A Young Neurologist Discusses Life After ALS Diagnosis
|
Jul 28, 2022 |
|
Prime C: NeuroSense on their ALS Treatment
|
Jun 28, 2022 |
|
Ric Starry and Kevin Porter: 20 Years of the Tri-State Trek
|
May 13, 2022 |
|
José Fajardo on Participating in a Clinical Trial
|
Apr 15, 2022 |
|
Coya Therapeutics: Treg Therapy in ALS
|
Mar 01, 2022 |
|
Sally Stewart of the Denver Wine Merchant: Staying Involved with Her Passion in the Face of ALS
|
Jan 12, 2022 |
|
Project Euphonia: ALS TDI Works with Google to Help People with ALS Communicate
|
Jan 06, 2022 |
|
Dr. Kyle Denton: Induced Pluripotent Stem Cells in ALS Research
|
Dec 16, 2021 |
|
Carol Hamilton: How ALS TDI Works to Help Veterans with ALS
|
Nov 16, 2021 |
|
Tavares Speer: Spreading ALS Awareness on Social Media
|
Nov 08, 2021 |
|
Steve Cochlan and the ALS Family of Faith
|
Nov 01, 2021 |
|
ALS TDI: The Drug Discovery Engine for ALS
|
Oct 25, 2021 |
|
I'm Dying to Tell You: Lorri Carey on Living – and Podcasting – with ALS
|
Sep 17, 2021 |
|
What is a Biomarker?
|
Sep 08, 2021 |
|
MERIDIAN: Apellis Discusses their Phase 2 ALS Trial
|
Aug 10, 2021 |
|
Lou Gehrig Day: Celebrating a Legend and Raising ALS Awareness
|
May 14, 2021 |
|
Braingate: Helping People with ALS Control Devices with their Minds
|
Feb 26, 2021 |
|
Lisa Cross Bonahoom: Fighting ALS for Herself and Her Family
|
Dec 29, 2020 |
|
Neurofilament Light Chain: A Potential ALS Biomarker?
|
Dec 29, 2020 |
|
Daniel Barvin: Working to Create a Future Without Familial ALS
|
Dec 03, 2020 |
|
Joe Lynch and Larry Cepuran: Living with ALS and Supporting ALS TDI
|
Sep 01, 2020 |
|
Steve Saling: 10 Years of the ALS Residence
|
Aug 13, 2020 |
|
AT 1501, Part 1: The Science Behind the Drug
|
Aug 11, 2020 |
|
Dr. Steve Perrin: What is a Clinical Trial?
|
Jul 07, 2020 |
|
Dr. Steve Perrin: What Does it Mean to Replicate or Validate a Study?
|
Jun 03, 2020 |
|
Day by Day: The Reich Family Fights ALS
|
May 29, 2020 |
|
The Lloyd Brothers: Racing for ALS
|
Feb 07, 2020 |
|
What to Know About CMAP
|
Jan 27, 2020 |
|
What to know about AMX0035
|
Oct 31, 2019 |
|
Collin Hadley: Choosing to use Mechanical Ventilation for ALS
|
Oct 16, 2019 |
|
Samantha Van Saun: Building an ALS Community
|
Oct 15, 2019 |
|
NurOwn and the Hope for Stem Cells in ALS?
|
Oct 15, 2019 |
|
Tamara Hillard: Anticipating Needs as an ALS Caregiver
|
Oct 15, 2019 |
|
Jeff Roosa: Uniting First Responders to End ALS
|
Sep 18, 2019 |
|
What to know about CuATSM clinical trials
|
Sep 18, 2019 |
|
What Do We Know About C9ORF72?
|
Sep 18, 2019 |